These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37467485)

  • 1. Metabolomic analysis identifies the regulation of lipid metabolism pathway as potential mechanisms of Jiangzhi decoction against non-alcoholic fatty liver disease.
    Wang L; Zhi Y; Ye Y; Zhang M; Mai Z; Xia W; Song Y
    J Pharm Pharmacol; 2023 Oct; 75(10):1366-1377. PubMed ID: 37467485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
    Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
    Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
    Yao X; Xia F; Tang W; Xiao C; Yang M; Zhou B
    J Ethnopharmacol; 2018 Feb; 212():208-215. PubMed ID: 29031784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyene Phosphatidylcholine Ameliorates High Fat Diet-Induced Non-alcoholic Fatty Liver Disease
    Lu Y; Feng T; Zhao J; Jiang P; Xu D; Zhou M; Dai M; Wu J; Sun F; Yang X; Lin Q; Pan W
    Front Physiol; 2022; 13():810143. PubMed ID: 35295576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corilagin prevents non-alcoholic fatty liver disease
    Liao M; Zhang R; Wang Y; Mao Z; Wu J; Guo H; Zhang K; Jing Y; Zhang C; Song H; Chen X; Wei G
    Front Nutr; 2022; 9():983450. PubMed ID: 36071929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.
    Zheng C; Nie H; Pan M; Fan W; Pi D; Liang Z; Liu D; Wang F; Yang Q; Zhang Y
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116967. PubMed ID: 37506783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model.
    Sun R; Xu D; Wei Q; Zhang B; Aa J; Wang G; Xie Y
    Biomed Pharmacother; 2020 Mar; 123():109721. PubMed ID: 31865143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS.
    Yan X; Li L; Liu P; Xu J; Wang Z; Ding L; Yang L
    J Pharm Biomed Anal; 2022 Mar; 211():114620. PubMed ID: 35124446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial metabolomic profiling for elucidating the alleviating potential of
    Yang XX; Wei JD; Mu JK; Liu X; Li FJ; Li YQ; Gu W; Li JP; Yu J
    World J Gastroenterol; 2019 Nov; 25(43):6404-6415. PubMed ID: 31798277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic-proteomic combination analysis reveals the targets and molecular pathways associated with hydrogen sulfide alleviating NAFLD.
    Liu Z; Liu M; Fan M; Pan S; Li S; Chen M; Wang H
    Life Sci; 2021 Jan; 264():118629. PubMed ID: 33131747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
    McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
    JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.
    Yin K; Zhou X; Jiang W; Wang L; Dai Z; Tang B
    Dis Markers; 2021; 2021():9963534. PubMed ID: 34239622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jujing Zhuyu decoction inhibits apoptosis in rats with asthenozoospermia by regulating the mitochondrial apoptosis pathway.
    Lin X; Li Q; Li H; Li C; Ye P; Chen S; Lu Y; Yuan Z; Qin G
    Andrologia; 2022 Dec; 54(11):e14632. PubMed ID: 36379453
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhu M; Hao S; Liu T; Yang L; Zheng P; Zhang L; Ji G
    Oncotarget; 2017 Oct; 8(47):82621-82631. PubMed ID: 29137289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid metabolomic analysis in exosomes of osteonecrosis of the femoral head based on ultra performance liquid chromatography-tandem mass spectrometry].
    Guo M; Zhang J
    Se Pu; 2022 Feb; 40(2):123-129. PubMed ID: 35080158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules.
    Dang Y; Hao S; Zhou W; Zhang L; Ji G
    BMC Complement Altern Med; 2019 Jan; 19(1):8. PubMed ID: 30616587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic association study uncovered H3K27 acetylation enhancers and dysregulated genes in high-fat-diet-induced nonalcoholic fatty liver disease in rats.
    Ma J; You D; Chen S; Fang N; Yi X; Wang Y; Lu X; Li X; Zhu M; Xue M; Tang Y; Wei X; Huang J; Zhu Y
    Epigenomics; 2022 Dec; 14(23):1523-1540. PubMed ID: 36851897
    [No Abstract]   [Full Text] [Related]  

  • 20. The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet.
    Chen M; Guo WL; Li QY; Xu JX; Cao YJ; Liu B; Yu XD; Rao PF; Ni L; Lv XC
    Food Funct; 2020 Apr; 11(4):3316-3331. PubMed ID: 32226996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.